UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1

PloS one, 2018-08, Vol.13 (8), p.e0202914-e0202914

2018

Volltextzugriff (PDF)

Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives

Current pharmaceutical design, 2019, Vol.25 (25), p.2697-2715

2019

Volltextzugriff (PDF)

Neuroprotective potential of adenosine A 1 receptor partial agonists in experimental models of cerebral ischemia

Journal of neurochemistry, 2019-04, Vol.149 (2), p.211-230

2019

Volltextzugriff (PDF)

Pharmacological characterisation of novel adenosine A3 receptor antagonists

Scientific reports, 2020-11, Vol.10 (1), p.20781, Article 20781

2020

Volltextzugriff (PDF)

7‐Amino‐2‐aryl/hetero‐aryl‐5‐oxo‐5,8‐dihydro[1,2,4]triazolo[1,5‐a]pyridine‐6‐carbonitriles: Synthesis and adenosine receptor binding studies

Chemical biology & drug design, 2019-08, Vol.94 (2), p.1568-1573

2019

Volltextzugriff (PDF)

Synthesis, adenosine receptor binding and molecular modelling studies of novel thieno[2,3‐d]pyrimidine derivatives

Chemical biology & drug design, 2018-04, Vol.91 (4), p.962-969

2018

Volltextzugriff (PDF)

Targeting G Protein‐Coupled Receptors with Magnetic Carbon Nanotubes: The Case of the A3 Adenosine Receptor

ChemMedChem, 2020-10, Vol.15 (20), p.1909-1920

2020

Volltextzugriff (PDF)

Analysis of receptor oligomerization by FRAP microscopy

Nature methods, 2009-03, Vol.6 (3), p.225-230

2009

Volltextzugriff (PDF)

Adenosine Receptor Ligands: Coumarin–Chalcone Hybrids as Modulating Agents on the Activity of hARs

Molecules (Basel, Switzerland), 2020-09, Vol.25 (18), p.4306

2020

Volltextzugriff (PDF)

Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode

Journal of chemical information and modeling, 2018-04, Vol.58 (4), p.794-815

2018

Volltextzugriff (PDF)

A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?

Molecules (Basel, Switzerland), 2022-04, Vol.27 (8), p.2386

2022

Volltextzugriff (PDF)

Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment

PloS one, 2018-01, Vol.13 (1), p.e0188212

2018

Volltextzugriff (PDF)

Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia

Journal of neurochemistry, 2019-04, Vol.149 (2), p.211-230

2019

Volltextzugriff (PDF)

Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors

Biomolecules (Basel, Switzerland), 2023-11, Vol.13 (11), p.1610

2023

Volltextzugriff (PDF)

Coumarins and adenosine receptors: New perceptions in structure–affinity relationships

Chemical biology & drug design, 2018-01, Vol.91 (1), p.245-256

2018

Volltextzugriff (PDF)

Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists

Journal of pharmacy and pharmacology, 2013-05, Vol.65 (5), p.697-703

2013

Volltextzugriff (PDF)

The current status of pharmacotherapy for the treatment of Parkinson’s disease: transition from single-target to multitarget therapy

Drug discovery today, 2019-09, Vol.24 (9), p.1769-1783

2019

Volltextzugriff (PDF)

Bronchospasmolytic and Adenosine Binding Activity of 8- (Proline / Pyrazole)- Substituted Xanthine Derivatives

Current drug discovery technologies, 2021, Vol.18 (5), p.e22092020186181

2021

Volltextzugriff (PDF)

Organoruthenium Antagonists of Human A3 Adenosine Receptors

Chemistry : a European journal, 2013-06, Vol.19 (25), p.8321-8330

2013

Volltextzugriff (PDF)

The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives

PloS one, 2015-12, Vol.10 (12), p.e0143504

2015

Volltextzugriff (PDF)

Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins

Journal of pharmacy and pharmacology, 2013-11, Vol.65 (11), p.1590-1597

2013

Volltextzugriff (PDF)

Design, Synthesis and Evaluation of New Indolylpyrimidylpiperazines for Gastrointestinal Cancer Therapy

Molecules (Basel, Switzerland), 2019-10, Vol.24 (20), p.3661

2019

Volltextzugriff (PDF)

Correction to: Agonists activate different A2B adenosine receptor signaling pathways in MDA-MB-231 breast cancer cells with distinct potencies

Naunyn-Schmiedeberg's archives of pharmacology, 2020-11, Vol.393 (11), p.2239-2239

2020

Volltextzugriff (PDF)

Agonists activate different A2B adenosine receptor signaling pathways in MBA-MD-231 breast cancer cells with distinct potencies

Naunyn-Schmiedeberg's archives of pharmacology, 2019-12, Vol.392 (12), p.1515-1521

2019

Volltextzugriff (PDF)

Synthesis and Evaluation of a New Series of 8-(2-Nitroaryl)Xanthines as Adenosine Receptor Ligands

Drug development research, 2016-08, Vol.77 (5), p.241-250

2016

Volltextzugriff (PDF)

1 – 25 von 291

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(276)
Mit Volltextzugriff
(272)

Publikationsform

Artikel
(290)
Buchkapitel
(1)

Sprache

Englisch
(288)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(95)
Animals
(91)
Science & Technology
(84)
Life Sciences & Biomedicine
(80)
Biological And Medical Sciences
(61)
Pharmacology & Pharmacy
(54)
Adenosine Receptors
(51)
Adenosine
(50)
Cho Cells
(49)
Cricetinae
(48)
Structure-Activity Relationship
(47)
Medical Sciences
(45)
Pharmacology. Drug Treatments
(40)
Neuropharmacology
(35)
Chemistry, Medicinal
(34)
Neurotransmitters. Neurotransmission. Receptors
(34)
Cricetulus
(31)
Radioligand Assay
(31)
Adenosine - Analogs & Derivatives
(28)
Models, Molecular
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1

Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives

Neuroprotective potential of adenosine A 1 receptor partial agonists in experimental models of cerebral ischemia

Pharmacological characterisation of novel adenosine A3 receptor antagonists

7‐Amino‐2‐aryl/hetero‐aryl‐5‐oxo‐5,8‐dihydro[1,2,4]triazolo[1,5‐a]pyridine‐6‐carbonitriles: Synthesis and adenosine receptor binding studies

Synthesis, adenosine receptor binding and molecular modelling studies of novel thieno[2,3‐d]pyrimidine derivatives

Targeting G Protein‐Coupled Receptors with Magnetic Carbon Nanotubes: The Case of the A3 Adenosine Receptor

Analysis of receptor oligomerization by FRAP microscopy

Adenosine Receptor Ligands: Coumarin–Chalcone Hybrids as Modulating Agents on the Activity of hARs

Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode

A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?

Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment

Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia

Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors

Coumarins and adenosine receptors: New perceptions in structure–affinity relationships

Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists

The current status of pharmacotherapy for the treatment of Parkinson’s disease: transition from single-target to multitarget therapy

Bronchospasmolytic and Adenosine Binding Activity of 8- (Proline / Pyrazole)- Substituted Xanthine Derivatives

Organoruthenium Antagonists of Human A3 Adenosine Receptors

The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives

Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins

Design, Synthesis and Evaluation of New Indolylpyrimidylpiperazines for Gastrointestinal Cancer Therapy

Correction to: Agonists activate different A2B adenosine receptor signaling pathways in MDA-MB-231 breast cancer cells with distinct potencies

Agonists activate different A2B adenosine receptor signaling pathways in MBA-MD-231 breast cancer cells with distinct potencies

Synthesis and Evaluation of a New Series of 8-(2-Nitroaryl)Xanthines as Adenosine Receptor Ligands

Suchergebnisse filtern